Uganda must strengthen the systems that move university research beyond prototypes and publications into policies, public services, products and enterprises that improve people’s lives, Hon. Eng. Jonard Asiimwe Akiiki, Minister in charge of Science, Technology and Innovation in the Office of the President (STI-OP), has said.
He made the call during a visit to Makerere University School of Public Health on Wednesday, 16 September 2026, as part of his wider engagement with Makerere University’s research and innovation ecosystem. Accompanied by University Management, led by Vice-Chancellor Prof. Barnabas Nawangwe, the Minister met researchers presenting work across major public health priorities before touring the School’s new building.
Hon. Eng. Asiimwe linked the challenge to Uganda’s Tenfold Growth Strategy, which targets expanding the country’s GDP from nearly USD 50 billion in 2023 to USD 500 billion by 2040. He argued that science, technology and innovation must help deliver that ambition by raising productivity, improving public services and creating viable enterprises.
“The Tenfold Growth Strategy will not be achieved by one particular project alone,” he stated. “It will be achieved when science, technology and innovation repeatedly raise the productivity and incomes of millions of ordinary people.”
The work presented at MakSPH showed how public health research can contribute to that ambition by shaping clinical guidance and national policy, strengthening systems that improve services and protect population health, and advancing technologies towards wider testing and adoption.
One such example was the PURPOSE 1 study, a 2022–2024 trial that evaluated Gilead Sciences’ twice-yearly injectable lenacapavir for HIV prevention among adolescent girls and young women. Prof. Noah Kiwanuka served as Site Principal Investigator for MakSPH’s work at Makerere-Kalangala site through the UVRI-IAVI collaboration. The trial recorded no HIV infections among participants who received lenacapavir, contributing evidence that informed regulatory decisions and WHO’s 2025 recommendation of the drug as an additional HIV prevention option.
In maternal and newborn health, MakSPH’s Centre of Excellence for Maternal, Newborn and Child Health recently partnered with St. Francis Hospital Nsambya to establish Uganda’s first human milk bank and generate evidence on the safe use of pasteurised donor milk. The work has now contributed to Uganda’s first National Donor Human Milk Guidelines and provides a model that other hospitals could adopt.
The exhibition also showed how university expertise can strengthen national systems. Through the Monitoring and Evaluation Technical Support (METS) Programme, MakSPH worked with the Ministry of Health for more than 15 years to develop and support platforms for health reporting, disease surveillance and programme management. The U.S. CDC funded the programme through PEPFAR, providing US$103.8 million across three five-year grants. In March 2026, MakSPH transitioned 16 digital health systems developed through METS, together with their supporting infrastructure, to Ministry of Health stewardship.
Makerere University School of Public Health Dean Prof. Rhoda Wanyenze said the School embeds teaching and research within communities, health facilities and public institutions through its “Public Health School Without Walls” model, designing research around the problems it must address and the value it can create.
“For us, translation is not alien. It is where we start when designing our research,” Prof. Wanyenze noted. “We examine what drives ill health and what we can do to solve the problem. As we consider translation and commercialisation, we must define how scientific impact grows into societal impact and track that contribution through health outcomes and economic growth.”
That approach informs VectorCam, an artificial intelligence-enabled smartphone tool that MakSPH is evaluating in Mayuge and Adjumani districts. It enables community health workers to identify mosquitoes by species, sex and feeding status, generating faster data for malaria-control decisions. Prof. Peter Waiswa serves as Uganda Principal Investigator for the Gates Foundation-funded project, which MakSPH implements with Johns Hopkins University. The partners plan to extend it to 22 districts and assess its performance under routine conditions in 12.
Watch how VectorCam uses a smartphone and artificial intelligence to identify mosquitoes and strengthen malaria surveillance:
The School’s national survey work also demonstrates local capacity to generate evidence for policy. Uganda launched the 2024–2025 Uganda Population-based HIV Impact Assessment (UPHIA) in May 2025 with support from the U.S. Government and technical leadership from MakSPH. The Ministry of Health expects to release the findings on 1 October 2026, providing updated evidence on HIV prevalence, new infections, viral suppression, service coverage and associated risk behaviours to guide the country’s future HIV response.
The School also led Performance Monitoring for Action (PMA) Uganda, a nationally representative platform that generated recurring evidence on contraceptive use, access and service quality. Working with the Ministry of Health and other partners, it enabled Uganda to track change, identify persistent gaps and guide family-planning policy and investment.
This combination of evidence generation and local capacity gives practical expression to Makerere University’s Strategic Plan 2025–2030, launched in July 2026, which seeks to build a sustainable, research-led and responsive university. During a visit to MakSPH on 18 June 2026, Prof. Barnabas Nawangwe described the School as a model of that institutional direction.
“I think the School of Public Health is the perfect example of what a research-led unit should be,” Prof. Nawangwe said. “You are really showing the way for the rest of the University and what we should be as a research-led university.”
The work supports priorities under Uganda’s Fourth National Development Plan (NDP IV), including stronger health research, innovation and uptake of locally generated solutions. Speaking at a public dialogue on health financing jointly organised by MakSPH and partners in April 2026, Prof. Nawangwe said Makerere attracts more than UGX 1 trillion into Uganda annually through research and urged the Government to increase support for the University’s national role.
Today, the Government allocates about UGX 25 billion annually through the Makerere University Research and Innovations Fund (Mak-RIF) to support research and innovation across Makerere. Beyond Mak-RIF, it recently contributed UGX 14 billion to the construction of the new MakSPH building. Work began in 2020 and remains on course for completion in December 2026.
The facility will expand space for teaching, research, laboratories and collaboration. The School’s next infrastructure priority is a specialised environmental health laboratory to investigate health risks associated with air, water, food and other environmental exposures.
Through STI-OP, the Government also supports the NUTRIMEAL Project. Dr Barbara Eva Kirunda leads the project, which brings together MakSPH and Makerere University’s School of Food Technology, Nutrition and Bioengineering to develop a non-dairy probiotic beverage from locally available finger millet and beetroot for people living with HIV. The team will test its safety and effects on immune and nutritional outcomes among 432 participants.
Hon. Eng. Asiimwe placed that support within a longer pathway from research to use. He said developing and testing an innovation represent only part of the journey and called for stronger systems to move viable innovations into policy, public services, products and enterprises.
“Every innovation should be able to name its user, define the problem it solves and show the value it creates,” he said. “We should move beyond saying, ‘We developed a prototype,’ to showing who uses it, who manufactures it, how it reaches the market and how it will grow.”
Reaching that point requires the capacity to generate and test evidence, alongside collaboration among universities, government and industry in validation, standards, intellectual property, financing, manufacturing, procurement and public trust.
Public health research creates value not only through commercial products but also evidence that changes policy, strengthens surveillance, improves clinical practice and guides national programmes. The challenge now is to move the strongest research into use and turn it into better services, greater productivity and healthier lives, all essential to Uganda’s tenfold growth ambition.
